A novel perspective on stem cell homing and mobilization: Review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients

Leukemia

Volumn 26, Issue 1, 2012, Pages 63-72

  Ratajczak, M Z ^a,b   Kim, C H ^a   Abdel Latif, A ^c   Schneider, G ^a   Kucia, M ^a,b   Morris, A J ^c   Laughlin, M J ^d   Ratajczak, J ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

C1P; C3a; cathelicidin; CXCR4; S1P; SDF 1

Indexed keywords

ANAPHYLATOXIN; C3A ANAPHYLATOXIN; CATHELICIDIN; CATION; CERAMIDE 1 PHOSPHATE; CHEMOATTRACTANT; CHEMOKINE RECEPTOR CXCR4; LIPID; SPHINGOSINE 1 PHOSPHATE; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

BONE MARROW; CELL HOMING; CELL ISOLATION; CELL MIGRATION; CHEMOTAXIS; DOWN REGULATION; HUMAN; MICROENVIRONMENT; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; REVIEW; STEM CELL; STEM CELL MOBILIZATION;

ANIMALS; CATIONS; CHEMOKINE CXCL12; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LIPIDS; MICE; PEPTIDES; RECEPTORS, CXCR4;

EID: 84856733415     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.242     Document Type: Review

References (99)

1. Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001; 98: 1289-1297.
2. Peled A, Grabovsky V, Habler L, Sandbank J, Arenzana-Seisdedos F, Petit I et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow. J Clin Invest 1999; 104: 1199-1211. (Pubitemid 29536291)
3. Levesque JP, Hendy J, Winkler IG, Takamatsu Y, Simmons PJ. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp Hematol 2003; 31: 109-117. (Pubitemid 36184635)
4. Levesque JP, Hendy J, Takamatsu Y, Williams B, Winkler IG, Simmons PJ. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 2002; 30: 440-449. (Pubitemid 34556735)
5. Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003; 111: 187-196. (Pubitemid 36105917)
6. Pelus LM, Bian H, King AG, Fukuda S. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4. Blood 2004; 103: 110-119. (Pubitemid 38029925)
7. Hanel P, Andréani P, Graler MH. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 2007; 21: 1202-1209. (Pubitemid 46495709)
8. Seitz G, Boehmle, AM, Kanz L, Möhle R. The role of sphingosine 1-phosphate receptors in the trafficking of hematopoietic progenitor cells. Ann N Y Acad Sci 2005; 1044: 84-89. (Pubitemid 40967597)
9. Ratajczak MZ, Lee H, Wysoczynski M, Wan W, Marlicz W, Laughlin MJ et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 2010; 24: 976-985.
10. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999; 10: 463-471. (Pubitemid 29205482)
11. Christopherson II KW, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305: 1000-1003. (Pubitemid 39071774)
12. Onai N, Zhang YY, Yoneyama H, Kitamura T, Ishikawa S, Matsushima K. Impairment of lymphopoiesis and myelopoiesis in mice reconstituted with bone marrow-hematopoietic progenitor cells expressing SDF-1-intrakine. Blood 2000; 96: 2074-2080.
13. Kim CH, Wu W, Wysoczynski M, Abdel-Latif A, Sunkara M, Morris A et al. Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors. Leukemia 2012; 26: 106-116.
14. Massberg S, Schaerli P, Knezevic-Maramica I, Köllnberger M, Tubo N, Moseman EA et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007; 131: 994-1008. (Pubitemid 350138089)
15. Ratajczak MZ, Kim CH, Wojakowski W, Janowska-Wieczorek A, Kucia M, Ratajczak J. Innate immunity as orchestrator of stem cell mobilization. Leukemia 2010; 24: 1667-1675.
16. Dar A, Schajnovitz A, Lapid K, Kalinkovich A, Itkin T, Ludin A et al. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells. Leukemia 2011; 25: 1286-1296.
17. Granado MH, Gangoiti P, Ouro A, Arana L, González M, Trueba M et al. Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor. Cell Signal 2009; 21: 405-412.
18. Arana L, Gangoiti P, Ouro A, Trueba M, Gómez-Muñoz A. Ceramide and ceramide 1-phosphate in health and disease. Lipids Health Dis 2010; 9: 15-26.
19. Lee HM, Wu W, Wysoczynski M, Liu R, Zuba-Surma EK, Kucia M et al. Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes. Leukemia 2009; 23: 2052-2062.
20. Fukuoka Y, Hugli TE. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control. J Immunol 1990; 145: 1851-1858. (Pubitemid 20336754)
21. Mousli M, Hugli TE, Landry Y, Bronner C. A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J Immunol 1992; 148: 2456-2461.
22. Ratajczak MZ, Reca R, Wysoczynski M, Kucia M, Baran JT, Allendorf DJ et al. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia 2004; 18: 1482-1490. (Pubitemid 39264070)
23. Bonig H, Priestley GV, Oehler V, Papayannopoulou T. Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC. Exp Hematol 2007; 35: 326-334. (Pubitemid 46135813)
24. Simón MF, Andrew C, Miriam M, Paul SF. Circadian rhythms influence hematopoietic stem cells. Curr Opin Hematol 2009; 16: 235-242.
25. Möbius-Winkler S, Hilberg T, Menzel K, Golla E, Burman A, Schuler G et al. Time-dependent mobilization of circulating progenitor cells during strenuous exercise in healthy individuals. J Appl Physiol 2009; 107: 1943-1950.
26. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005; 6: 1182-1190. (Pubitemid 43045626)
27. Kucia M, Zhang YP, Reca R, Wysoczynski M, Machalinski B, Majka M et al. Cells enriched in markers of neural tissuecommitted stem cells reside in the bone marrow and are mobilized into the peripheral blood following stroke. Leukemia 2006; 20: 18-28.
28. Wojakowski W, Tendera M, Kucia M, Zuba-Surma E, Paczkowska E, Ciosek J et al. Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol 2009; 53: 1-9.
29. Wojakowski W, Landmesser U, Bachowski R, Jadczyk T, Tendera M. Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia 2012; 26: 23-33.
30. Paczkowska E, Kucia M, Koziarska D, Halasa M, Safranow K, Masiuk M et al. Clinical evidence that very small embryonic-like stem cells are mobilized into peripheral blood in patients after stroke. Stroke 2009; 40: 1237-1244.
31. Lee HM, Wysoczynski M, Liu R, Shin DM, Kucia M, Botto M et al. Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes. Leukemia 2010; 24: 573-582.
32. Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 2002; 195: 1145-1154. (Pubitemid 34517140)
33. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005; 106: 1901-1910. (Pubitemid 41291700)
34. Vagima Y, Lapid K, Kollet O, Goichberg P, Alon R, Lapidot T. Pathways implicated in stem cell migration: the SDF-1/CXCR4 axis. Methods Mol Biol 2011; 750: 277-289.
35. Tarnowski M, Liu R, Wysoczynski M, Ratajczak J, Kucia M, Ratajczak MZ. CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells. Eur J Haematol 2010; 85: 472-483.
36. Tarnowski M, Grymula K, Liu R, Tarnowska J, Drukala J, Ratajczak J et al. Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancerassociated fibroblasts. Mol Cancer Res 2010; 8: 1328-1343.
37. Basu S, Ray NT, Atkinson SJ, Broxmeyer HE. Protein phosphatase 2A plays an important role in stromal cell-derived factor-1/CXC chemokine ligand 12-mediated migration and adhesion of CD34+ cells. J Immunol 2007; 179: 3075-3085.
38. Gazitt Y, Liu Q. Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34+ cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients. Stem cells 2001; 19: 37-45. (Pubitemid 32057970)
39. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858-864. (Pubitemid 39070860)
40. Greenbaum AM, Link DC. Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia 2011; 25: 211-217.
41. Lynch KR. Lysophospholipid receptor nomenclature. Biochim Biophys Acta 2002; 1582: 70-71. (Pubitemid 34634112)
42. Sanchez T, Hla T. Structural and functional characteristics of S1P receptors. J Cell Biochem 2004; 92: 913-922. (Pubitemid 44264241)
43. Rivera J, Proia RL, Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 2008; 8: 753-763.
44. Jo E, Sanna MG, Gonzalez-Cabrera PJ, Thangada S, Tigyi G, Osborne DA et al. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem Biol 2005; 12: 703-715. (Pubitemid 43142048)
45. Walter DH, Rochwalsky U, Reinhold J, Seeger F, Aicher A, Urbich C et al. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler Thromb Vasc Biol 2007; 27: 275-282. (Pubitemid 46143040)
46. Michaud J, Im DS, Hla T. Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation. J Immunol 2010; 184: 1475-1483.
47. Graler MH, Goetzl EJ. The immunosuppressant FTY720 downregulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J 2004; 18: 551-553.
48. Boath A, Graf C, Lidome E, Ullrich T, Nussbaumer P, Bornancin F. Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: comparative analysis to glucosylceramide and sphingomyelin. J Biol Chem 2008; 283: 8517-8526.
49. Hannun YA, Obeid LM. The Ceramide-centric universe of lipidmediated cell regulation: stress encounters of the lipid kind. J Biol Chem 2002; 277: 25847-25850. (Pubitemid 34967060)
50. Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, Wang E et al. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 2006; 1758: 1864-1884. (Pubitemid 44879367)
51. Gomez-Munoz A, Kong JY, Salh B, Steinbrecher UP. Ceramide-1-phosphate blocks apoptosis through inhibition of acidsphingomyelinase in macrophages. J Lipid Res 2004; 45: 99-105. (Pubitemid 38176619)
52. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004; 427: 355-360. (Pubitemid 38133663)
53. Allende ML, Dreier JL, Mandala S, Proia RL. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 2004; 279: 15396-15401. (Pubitemid 38618938)
54. Schwab SR, Cyster JG. Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol 2007; 8: 1295-1301. (Pubitemid 350131168)
55. Pereira JP, Xu Y, Cyster JG. A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow. PLoS One 2010; 5: e9277.
56. Donovan EE, Pelanda R, Torres RM. S1P3 confers differential S1Pinduced migration by autoreactive and non-autoreactive immature B cells and is required for normal B-cell development. Eur J Immunol 2010; 40: 688-698.
57. Brindley DN, English D, Pilquil C, Buri K, Ling ZC. Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids. Biochim Biophys Acta 2002; 1582: 33-44. (Pubitemid 34634109)
58. Sciorra VA, Morris AJ. Roles for lipid phosphate phosphatases in regulation of cellular signaling. Biochim Biophys Acta 2002; 1582: 45-51. (Pubitemid 34634110)
59. Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, Cyster JG. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 2005; 309: 1735-1739. (Pubitemid 41285945)
60. Long J, Darroch P, Wan KF, Kong KC, Ktistakis N, Pyne NJ et al. Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools. Biochem J 2005; 391: 25-32. (Pubitemid 41445472)
61. Mechtcheriakova D, Wlachos A, Sobanov J, Kopp T, Reuschel R, Bornancin F et al. Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell Signal 2007; 19: 748-760. (Pubitemid 46275367)
62. Zhao Y, Kalari SK, Usatyuk PV, Gorshkova I, He D, Watkins T et al. Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J Biol Chem 2007; 282: 14165-14177. (Pubitemid 47100473)
63. Pappu R, Schwab SR, Cornelissen I, Pereira JP, Regard JB, Xu Y et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007; 316: 295-298. (Pubitemid 46633109)
64. Hannun YA, Obeid LM. Principles of bioactive lipid signaling: lessons from sphingolipids.Nat RevMol Cell Biol 2008; 9: 139-150. (Pubitemid 351158911)
65. Peest U, Sensken SC, Andréani P, Hänel P, Van Veldhoven PP, Gräler MH. S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake. J Cell Biochem 2008; 104: 756-772. (Pubitemid 351830827)
66. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 2000; 106: 951-961.
67. Lorenz JN, Arend LJ, Robitz R, Paul RJ, MacLennan AJ. Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice. Am J Physiol Regul Integr Comp Physiol 2007; 292: R440-R446. (Pubitemid 46089859)
68. Ishii I, Friedman B, Ye X, Kawamura S, McGiffert C, Contos JJ et al. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem 2001; 276: 33697-33704.
69. Escalante-Alcalde D, Hernandez L, Le Stunff H, Maeda R, Lee HS, Jr-Gang-Cheng et al. The lipid phosphatase LPP3 regulates extraembryonic vasculogenesis and axis patterning. Development 2003; 130: 4623-4637. (Pubitemid 37279415)
70. Allende ML, Sasaki T, Kawai H, Olivera A, Mi Y, van Echten-Deckert G et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 2004; 279: 52487-52492. (Pubitemid 39656625)
71. Lee H, Ratajczak MZ. Innate immunity: a key player in the mobilization of hematopoietic stem/progenitor cells. Arch Immunol Ther Exp 2009; 57: 269-278.
72. Lévesque JP, Helwani FM, Winkler IG. The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization. Leukemia 2010; 24: 1979-1992.
73. Ratajczak MZ, Reca R, Wysoczynski M, Yan J, Ratajczak J. Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)-implications for trafficking of CXCR4+ stem cells. Exp Hematol 2006; 34: 986-995. (Pubitemid 44080380)
74. Wysoczynski M, Reca R, Lee H, Wu W, Ratajczak J, Ratajczak MZ. Defective engraftment of C3aR-/-hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing. Leukemia 2009; 23: 1455-1461.
75. Bengtsson NE, Kim S, Lin L, Walter GA, Scott EW. Ultra-high-field MRI real-time imaging of HSC engraftment of the bone marrow niche. Leukemia 2011; 25: 1223-1231.
76. Ratajczak J, Reca R, Kucia M, Majka M, Allendorf DJ, Baran JT et al. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. Blood 2004; 103: 2071-2078. (Pubitemid 38326222)
77. Bandhuvula P, Honbo N, Wang GY, Jin ZQ, Fyrst H, Zhang M et al. S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart. Am J Physiol Heart Circ Physiol 2011; 300: H1753-H1761.
78. Borlongan CV. Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!. Leukemia 2011; e-pub ahead of print 5 July 2011; doi:10.1038/leu.2011.167.
79. Pelus LM, Fukuda S. Chemokine-mobilized adult stem cells; defining a better hematopoietic graft. Leukemia 2008; 22: 466-473. (Pubitemid 351386716)
80. Taichman RS. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 2005; 105: 2631-2639. (Pubitemid 40446251)
81. King AG, Horowitz D, Dillon SB, Levin R, Farese AM, MacVittie TJ et al. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta. Blood 2001; 97: 1534-1542. (Pubitemid 32217211)
82. Ramirez P, Rettig MP, Uy GL, Deych E, Holt MS, Ritchey JK et al. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood 2009; 114: 1340-1343.
83. Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006; 124: 407-421. (Pubitemid 43121987)
84. Spiegel A, Shivtiel S, Kalinkovich A, Ludin A, Netzer N, Goichberg P et al. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat Immunol 2007; 8: 1123-1131. (Pubitemid 47423760)
85. Topcuoglu P, Arat M, Dalva K, Ozcan M. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplant 2004; 33: 171-176. (Pubitemid 38180929)
86. Reca R, Cramer D, Yan J, Laughlin MJ, Janowska-Wieczorek A, Ratajczak J et al. A novel role of complement in mobilization: immunodeficient mice are poor granulocyte-colony stimulating factor mobilizers because they lack complement-activating immunoglobulins. Stem Cells 2007; 25: 3093-3100. (Pubitemid 350294435)
87. Farkas I, Baranyi L, Ishikawa Y, Okada N, Bohata C, Budai D et al. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9. J Physiol 2002; 539: 537-545. (Pubitemid 35175407)
88. Ruiz-Argü elles A, Llorente L. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmun Rev 2007; 6: 155-161.
89. Kimberley FC, Sivasankar B, Paul Morgan B. Alternative roles for CD59. Mol Immunol 2007; 44: 73-81. (Pubitemid 44647106)
90. Jalili A, Shirvaikar N, Marquez-Curtis L, Qui Y, Korol C, Lee H et al. Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells. Exp Hematol 2010; 38: 321-332.
91. Yatomi Y, Ruan F, Hakomori S, Igarashi Y. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995; 86: 193-202.
92. Sadir R, Imberty A, Baleux F, Lortat-Jacob H. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 2004; 279: 43854-43860. (Pubitemid 39390692)
93. Ou WC, Liu SM, Xiong LG, Li GQ, Tan MQ. Role of sphingosine 1-phosphate receptor signaling in hematopoietic stem/progenitor cell transmigration. Nan Fang Yi Ke Da Xue Xue Bao 2009; 29: 1862-1865.
94. Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 2009; 113: 5444-5455.
95. Hoggatt J, Pelus LM. Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. Leukemia 2010; 24: 1993-2002.
96. Pettus BJ, Kitatani K, Chalfant CE, Taha TA, Kawamori T, Bielawski J et al. The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate. Mol Pharmacol 2005; 68: 330-335. (Pubitemid 41058296)
97. Brizuela L, Rábano M, Peña A, Gangoiti P, Macarulla JM, Trueba M et al. Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion. J Lipid Res 2006; 47: 1238-1249. (Pubitemid 43830716)
98. Ratajczak MZ. Spotlight series on stem cell mobilization: many hands on the ball, but who is the quarterback? Leukemia 2010; 24: 1665-1666.
99. Ratajczak MZ, Kim CH, Wu W, Shin DM, Bryndza E, Kucia M et al. The role of innate immunity in trafficking of hematopoietic stem cellsFan emerging link between activation of complement cascade and chemotactic gradients of bioactive sphingolipids. Curr Top Innate Immun II; doi 10.1007/978-1-4614-0106-3-3.